These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 29502235

  • 1. Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model.
    Sui A, Zhong Y, Demetriades AM, Lu Q, Cai Y, Gao Y, Zhu Y, Shen X, Xie B.
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):951-961. PubMed ID: 29502235
    [Abstract] [Full Text] [Related]

  • 2. ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.
    Sui A, Zhong Y, Demetriades AM, Shen J, Su T, Yao Y, Gao Y, Zhu Y, Shen X, Xie B.
    Med Sci Monit; 2018 Aug 22; 24():5860-5873. PubMed ID: 30133427
    [Abstract] [Full Text] [Related]

  • 3. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.
    Wang W, Wang F, Lu F, Xu S, Hu W, Huang J, Gu Q, Sun X.
    Invest Ophthalmol Vis Sci; 2011 Sep 14; 52(10):7213-20. PubMed ID: 21813636
    [Abstract] [Full Text] [Related]

  • 4. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A, Chen X, Shen J, Demetriades AM, Yao Y, Yao Y, Zhu Y, Shen X, Xie B.
    Cell Death Dis; 2020 Oct 22; 11(10):901. PubMed ID: 33093455
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
    Wang WQ, Wang FH, Qin WX, Liu HY, Lu B, Chung C, Zhu J, Gu Q, Shi W, Wen C, Wu F, Zhang K, Sun XD.
    Mol Pharm; 2016 Sep 06; 13(9):2881-90. PubMed ID: 27089240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K, Saishin Y, Saishin Y, Silva RL, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M, Connelly S, Luo T, Campochiaro PA.
    FASEB J; 2003 May 06; 17(8):896-8. PubMed ID: 12670875
    [Abstract] [Full Text] [Related]

  • 11. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
    Zhang L, Shen X, Lu Q, Zhou Q, Gu J, Gan R, Zhang H, Sun X, Xie B.
    Graefes Arch Clin Exp Ophthalmol; 2012 May 06; 250(5):731-9. PubMed ID: 21881847
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T, Gong J, Xu Z, Wei Y, Duh EJ.
    Exp Eye Res; 2012 Jan 06; 94(1):41-8. PubMed ID: 22123068
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F, Bai Y, Yu W, Han N, Huang L, Zhao M, Zhou A, Zhao M, Li X.
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep 06; 251(9):2131-9. PubMed ID: 23740520
    [Abstract] [Full Text] [Related]

  • 16. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells.
    Chen S, Chakrabarti R, Keats EC, Chen M, Chakrabarti S, Khan ZA.
    Invest Ophthalmol Vis Sci; 2012 Dec 17; 53(13):8333-43. PubMed ID: 23150625
    [Abstract] [Full Text] [Related]

  • 17. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
    Nambu H, Umeda N, Kachi S, Oshima Y, Akiyama H, Nambu R, Campochiaro PA.
    J Cell Physiol; 2005 Jul 17; 204(1):227-35. PubMed ID: 15648096
    [Abstract] [Full Text] [Related]

  • 18. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W, Zhao M, Zhao S, Lu Q, Ni L, Zou C, Lu L, Xu X, Guan H, Zheng Z, Qiu Q.
    Inflamm Res; 2017 Feb 17; 66(2):157-166. PubMed ID: 27785530
    [Abstract] [Full Text] [Related]

  • 19. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
    Cheng G, He T, Xing Y.
    Eye (Lond); 2016 Jun 17; 30(6):877-87. PubMed ID: 26987588
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
    Yin Y, Zhou Z, Liu W, Chang Q, Sun G, Dai Y.
    Int J Biochem Cell Biol; 2017 Mar 17; 84():22-34. PubMed ID: 28064010
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.